-
1Academic Journal
المؤلفون: Esmée A. Bakker (11784684), Duck-chul Lee (2889482), Maria T. E. Hopman (8977214), Eline J. Oymans (11784687), Paula M. Watson (8983364), Paul D. Thompson (8900921), Dick H. J. Thijssen (8977229), Thijs. M. H. Eijsvogels (11784690)
مصطلحات موضوعية: Medicine, Biotechnology, Cancer, Science Policy, Infectious Diseases, vigorous physical activity, reducing adverse outcomes, optimize exercise prescription, findings may help, estimate hazard ratios, dose 8211, better 8221, study limitations include, lifestyle risk factors,
+moderate%22">xlink "> moderate, inactive 8221, +mvpa%22">xlink "> mvpa, gain maximal benefits, lifelines cohort study, 13 ), 09 ), 07 ), 004 ), cardiovascular risk factors, cardiovascular health status, 3 northern provinces, steep risk reduction, reported mvpa volumes, little health benefits Time: 0, 7, 95
-
2Academic Journal
المؤلفون: Esmée A. Bakker (11784684), Duck-chul Lee (2889482), Maria T. E. Hopman (8977214), Eline J. Oymans (11784687), Paula M. Watson (8983364), Paul D. Thompson (8900921), Dick H. J. Thijssen (8977229), Thijs. M. H. Eijsvogels (11784690)
مصطلحات موضوعية: Medicine, Biotechnology, Cancer, Science Policy, Infectious Diseases, vigorous physical activity, reducing adverse outcomes, optimize exercise prescription, findings may help, estimate hazard ratios, dose 8211, better 8221, study limitations include, lifestyle risk factors,
+moderate%22">xlink "> moderate, inactive 8221, +mvpa%22">xlink "> mvpa, gain maximal benefits, lifelines cohort study, 13 ), 09 ), 07 ), 004 ), cardiovascular risk factors, cardiovascular health status, 3 northern provinces, steep risk reduction, reported mvpa volumes, little health benefits Time: 0, 7, 95
-
3Academic Journal
المؤلفون: Esmée A. Bakker (11784684), Duck-chul Lee (2889482), Maria T. E. Hopman (8977214), Eline J. Oymans (11784687), Paula M. Watson (8983364), Paul D. Thompson (8900921), Dick H. J. Thijssen (8977229), Thijs. M. H. Eijsvogels (11784690)
مصطلحات موضوعية: Medicine, Biotechnology, Cancer, Science Policy, Infectious Diseases, vigorous physical activity, reducing adverse outcomes, optimize exercise prescription, findings may help, estimate hazard ratios, dose 8211, better 8221, study limitations include, lifestyle risk factors,
+moderate%22">xlink "> moderate, inactive 8221, +mvpa%22">xlink "> mvpa, gain maximal benefits, lifelines cohort study, 13 ), 09 ), 07 ), 004 ), cardiovascular risk factors, cardiovascular health status, 3 northern provinces, steep risk reduction, reported mvpa volumes, little health benefits Time: 0, 7, 95
-
4Academic Journal
المؤلفون: Esmée A. Bakker (11784684), Duck-chul Lee (2889482), Maria T. E. Hopman (8977214), Eline J. Oymans (11784687), Paula M. Watson (8983364), Paul D. Thompson (8900921), Dick H. J. Thijssen (8977229), Thijs. M. H. Eijsvogels (11784690)
مصطلحات موضوعية: Medicine, Biotechnology, Cancer, Science Policy, Infectious Diseases, vigorous physical activity, reducing adverse outcomes, optimize exercise prescription, findings may help, estimate hazard ratios, dose 8211, better 8221, study limitations include, lifestyle risk factors,
+moderate%22">xlink "> moderate, inactive 8221, +mvpa%22">xlink "> mvpa, gain maximal benefits, lifelines cohort study, 13 ), 09 ), 07 ), 004 ), cardiovascular risk factors, cardiovascular health status, 3 northern provinces, steep risk reduction, reported mvpa volumes, little health benefits Time: 0, 7, 95
-
5Academic Journal
المؤلفون: Esmée A. Bakker (11784684), Duck-chul Lee (2889482), Maria T. E. Hopman (8977214), Eline J. Oymans (11784687), Paula M. Watson (8983364), Paul D. Thompson (8900921), Dick H. J. Thijssen (8977229), Thijs. M. H. Eijsvogels (11784690)
مصطلحات موضوعية: Medicine, Biotechnology, Cancer, Science Policy, Infectious Diseases, vigorous physical activity, reducing adverse outcomes, optimize exercise prescription, findings may help, estimate hazard ratios, dose 8211, better 8221, study limitations include, lifestyle risk factors,
+moderate%22">xlink "> moderate, inactive 8221, +mvpa%22">xlink "> mvpa, gain maximal benefits, lifelines cohort study, 13 ), 09 ), 07 ), 004 ), cardiovascular risk factors, cardiovascular health status, 3 northern provinces, steep risk reduction, reported mvpa volumes, little health benefits Time: 0, 7, 95
-
6Academic Journal
المؤلفون: Esmée A. Bakker (11784684), Duck-chul Lee (2889482), Maria T. E. Hopman (8977214), Eline J. Oymans (11784687), Paula M. Watson (8983364), Paul D. Thompson (8900921), Dick H. J. Thijssen (8977229), Thijs. M. H. Eijsvogels (11784690)
مصطلحات موضوعية: Medicine, Biotechnology, Cancer, Science Policy, Infectious Diseases, vigorous physical activity, reducing adverse outcomes, optimize exercise prescription, findings may help, estimate hazard ratios, dose 8211, better 8221, study limitations include, lifestyle risk factors,
+moderate%22">xlink "> moderate, inactive 8221, +mvpa%22">xlink "> mvpa, gain maximal benefits, lifelines cohort study, 13 ), 09 ), 07 ), 004 ), cardiovascular risk factors, cardiovascular health status, 3 northern provinces, steep risk reduction, reported mvpa volumes, little health benefits Time: 0, 7, 95
-
7Academic Journal
المؤلفون: Esmée A. Bakker (11784684), Duck-chul Lee (2889482), Maria T. E. Hopman (8977214), Eline J. Oymans (11784687), Paula M. Watson (8983364), Paul D. Thompson (8900921), Dick H. J. Thijssen (8977229), Thijs. M. H. Eijsvogels (11784690)
مصطلحات موضوعية: Medicine, Biotechnology, Cancer, Science Policy, Infectious Diseases, vigorous physical activity, reducing adverse outcomes, optimize exercise prescription, findings may help, estimate hazard ratios, dose 8211, better 8221, study limitations include, lifestyle risk factors,
+moderate%22">xlink "> moderate, inactive 8221, +mvpa%22">xlink "> mvpa, gain maximal benefits, lifelines cohort study, 13 ), 09 ), 07 ), 004 ), cardiovascular risk factors, cardiovascular health status, 3 northern provinces, steep risk reduction, reported mvpa volumes, little health benefits Time: 0, 7, 95
-
8Academic Journal
المؤلفون: Esmée A. Bakker (11784684), Duck-chul Lee (2889482), Maria T. E. Hopman (8977214), Eline J. Oymans (11784687), Paula M. Watson (8983364), Paul D. Thompson (8900921), Dick H. J. Thijssen (8977229), Thijs. M. H. Eijsvogels (11784690)
مصطلحات موضوعية: Medicine, Biotechnology, Cancer, Science Policy, Infectious Diseases, vigorous physical activity, reducing adverse outcomes, optimize exercise prescription, findings may help, estimate hazard ratios, dose 8211, better 8221, study limitations include, lifestyle risk factors,
+moderate%22">xlink "> moderate, inactive 8221, +mvpa%22">xlink "> mvpa, gain maximal benefits, lifelines cohort study, 13 ), 09 ), 07 ), 004 ), cardiovascular risk factors, cardiovascular health status, 3 northern provinces, steep risk reduction, reported mvpa volumes, little health benefits Time: 0, 7, 95
-
9Academic Journal
المؤلفون: Esmée A. Bakker (11784684), Duck-chul Lee (2889482), Maria T. E. Hopman (8977214), Eline J. Oymans (11784687), Paula M. Watson (8983364), Paul D. Thompson (8900921), Dick H. J. Thijssen (8977229), Thijs. M. H. Eijsvogels (11784690)
مصطلحات موضوعية: Medicine, Biotechnology, Cancer, Science Policy, Infectious Diseases, vigorous physical activity, reducing adverse outcomes, optimize exercise prescription, findings may help, estimate hazard ratios, dose 8211, better 8221, study limitations include, lifestyle risk factors,
+moderate%22">xlink "> moderate, inactive 8221, +mvpa%22">xlink "> mvpa, gain maximal benefits, lifelines cohort study, 13 ), 09 ), 07 ), 004 ), cardiovascular risk factors, cardiovascular health status, 3 northern provinces, steep risk reduction, reported mvpa volumes, little health benefits Time: 0, 7, 95
-
10Academic Journal
المؤلفون: Esmée A. Bakker (11784684), Duck-chul Lee (2889482), Maria T. E. Hopman (8977214), Eline J. Oymans (11784687), Paula M. Watson (8983364), Paul D. Thompson (8900921), Dick H. J. Thijssen (8977229), Thijs. M. H. Eijsvogels (11784690)
مصطلحات موضوعية: Medicine, Biotechnology, Cancer, Science Policy, Infectious Diseases, vigorous physical activity, reducing adverse outcomes, optimize exercise prescription, findings may help, estimate hazard ratios, dose 8211, better 8221, study limitations include, lifestyle risk factors,
+moderate%22">xlink "> moderate, inactive 8221, +mvpa%22">xlink "> mvpa, gain maximal benefits, lifelines cohort study, 13 ), 09 ), 07 ), 004 ), cardiovascular risk factors, cardiovascular health status, 3 northern provinces, steep risk reduction, reported mvpa volumes, little health benefits Time: 0, 7, 95
-
11Academic Journal
المؤلفون: Esmée A. Bakker (11784684), Duck-chul Lee (2889482), Maria T. E. Hopman (8977214), Eline J. Oymans (11784687), Paula M. Watson (8983364), Paul D. Thompson (8900921), Dick H. J. Thijssen (8977229), Thijs. M. H. Eijsvogels (11784690)
مصطلحات موضوعية: Medicine, Biotechnology, Cancer, Science Policy, Infectious Diseases, vigorous physical activity, reducing adverse outcomes, optimize exercise prescription, findings may help, estimate hazard ratios, dose 8211, better 8221, study limitations include, lifestyle risk factors,
+moderate%22">xlink "> moderate, inactive 8221, +mvpa%22">xlink "> mvpa, gain maximal benefits, lifelines cohort study, 13 ), 09 ), 07 ), 004 ), cardiovascular risk factors, cardiovascular health status, 3 northern provinces, steep risk reduction, reported mvpa volumes, little health benefits Time: 0, 7, 95
-
12Academic Journal
المؤلفون: Esmée A. Bakker (11784684), Duck-chul Lee (2889482), Maria T. E. Hopman (8977214), Eline J. Oymans (11784687), Paula M. Watson (8983364), Paul D. Thompson (8900921), Dick H. J. Thijssen (8977229), Thijs. M. H. Eijsvogels (11784690)
مصطلحات موضوعية: Medicine, Biotechnology, Cancer, Science Policy, Infectious Diseases, vigorous physical activity, reducing adverse outcomes, optimize exercise prescription, findings may help, estimate hazard ratios, dose 8211, better 8221, study limitations include, lifestyle risk factors,
+moderate%22">xlink "> moderate, inactive 8221, +mvpa%22">xlink "> mvpa, gain maximal benefits, lifelines cohort study, 13 ), 09 ), 07 ), 004 ), cardiovascular risk factors, cardiovascular health status, 3 northern provinces, steep risk reduction, reported mvpa volumes, little health benefits Time: 0, 7, 95
-
13Image
المؤلفون: Esmée A. Bakker (11784684), Duck-chul Lee (2889482), Maria T. E. Hopman (8977214), Eline J. Oymans (11784687), Paula M. Watson (8983364), Paul D. Thompson (8900921), Dick H. J. Thijssen (8977229), Thijs. M. H. Eijsvogels (11784690)
مصطلحات موضوعية: Medicine, Biotechnology, Cancer, Science Policy, Infectious Diseases, vigorous physical activity, reducing adverse outcomes, optimize exercise prescription, findings may help, estimate hazard ratios, dose 8211, better 8221, study limitations include, lifestyle risk factors,
+moderate%22">xlink "> moderate, inactive 8221, +mvpa%22">xlink "> mvpa, gain maximal benefits, lifelines cohort study, 13 ), 09 ), 07 ), 004 ), cardiovascular risk factors, cardiovascular health status, 3 northern provinces, steep risk reduction, reported mvpa volumes, little health benefits Time: 0, 7, 95
-
14Image
المؤلفون: Esmée A. Bakker (11784684), Duck-chul Lee (2889482), Maria T. E. Hopman (8977214), Eline J. Oymans (11784687), Paula M. Watson (8983364), Paul D. Thompson (8900921), Dick H. J. Thijssen (8977229), Thijs. M. H. Eijsvogels (11784690)
مصطلحات موضوعية: Medicine, Biotechnology, Cancer, Science Policy, Infectious Diseases, vigorous physical activity, reducing adverse outcomes, optimize exercise prescription, findings may help, estimate hazard ratios, dose 8211, better 8221, study limitations include, lifestyle risk factors,
+moderate%22">xlink "> moderate, inactive 8221, +mvpa%22">xlink "> mvpa, gain maximal benefits, lifelines cohort study, 13 ), 09 ), 07 ), 004 ), cardiovascular risk factors, cardiovascular health status, 3 northern provinces, steep risk reduction, reported mvpa volumes, little health benefits Time: 0, 7, 95
-
15Image
المؤلفون: Esmée A. Bakker (11784684), Duck-chul Lee (2889482), Maria T. E. Hopman (8977214), Eline J. Oymans (11784687), Paula M. Watson (8983364), Paul D. Thompson (8900921), Dick H. J. Thijssen (8977229), Thijs. M. H. Eijsvogels (11784690)
مصطلحات موضوعية: Medicine, Biotechnology, Cancer, Science Policy, Infectious Diseases, vigorous physical activity, reducing adverse outcomes, optimize exercise prescription, findings may help, estimate hazard ratios, dose 8211, better 8221, study limitations include, lifestyle risk factors,
+moderate%22">xlink "> moderate, inactive 8221, +mvpa%22">xlink "> mvpa, gain maximal benefits, lifelines cohort study, 13 ), 09 ), 07 ), 004 ), cardiovascular risk factors, cardiovascular health status, 3 northern provinces, steep risk reduction, reported mvpa volumes, little health benefits Time: 0, 7, 95
-
16Image
المؤلفون: Esmée A. Bakker (11784684), Duck-chul Lee (2889482), Maria T. E. Hopman (8977214), Eline J. Oymans (11784687), Paula M. Watson (8983364), Paul D. Thompson (8900921), Dick H. J. Thijssen (8977229), Thijs. M. H. Eijsvogels (11784690)
مصطلحات موضوعية: Medicine, Biotechnology, Cancer, Science Policy, Infectious Diseases, vigorous physical activity, reducing adverse outcomes, optimize exercise prescription, findings may help, estimate hazard ratios, dose 8211, better 8221, study limitations include, lifestyle risk factors,
+moderate%22">xlink "> moderate, inactive 8221, +mvpa%22">xlink "> mvpa, gain maximal benefits, lifelines cohort study, 13 ), 09 ), 07 ), 004 ), cardiovascular risk factors, cardiovascular health status, 3 northern provinces, steep risk reduction, reported mvpa volumes, little health benefits Time: 0, 7, 95
-
17
المؤلفون: Esmée A. Bakker (11784684), Duck-chul Lee (2889482), Maria T. E. Hopman (8977214), Eline J. Oymans (11784687), Paula M. Watson (8983364), Paul D. Thompson (8900921), Dick H. J. Thijssen (8977229), Thijs. M. H. Eijsvogels (11784690)
مصطلحات موضوعية: Medicine, Biotechnology, Cancer, Science Policy, Infectious Diseases, vigorous physical activity, reducing adverse outcomes, optimize exercise prescription, findings may help, estimate hazard ratios, dose 8211, better 8221, study limitations include, lifestyle risk factors,
+moderate%22">xlink "> moderate, inactive 8221, +mvpa%22">xlink "> mvpa, gain maximal benefits, lifelines cohort study, 13 ), 09 ), 07 ), 004 ), cardiovascular risk factors, cardiovascular health status, 3 northern provinces, steep risk reduction, reported mvpa volumes, little health benefits Time: 0, 7, 95
-
18
المؤلفون: Esmée A. Bakker (11784684), Duck-chul Lee (2889482), Maria T. E. Hopman (8977214), Eline J. Oymans (11784687), Paula M. Watson (8983364), Paul D. Thompson (8900921), Dick H. J. Thijssen (8977229), Thijs. M. H. Eijsvogels (11784690)
مصطلحات موضوعية: Medicine, Biotechnology, Cancer, Science Policy, Infectious Diseases, vigorous physical activity, reducing adverse outcomes, optimize exercise prescription, findings may help, estimate hazard ratios, dose 8211, better 8221, study limitations include, lifestyle risk factors,
+moderate%22">xlink "> moderate, inactive 8221, +mvpa%22">xlink "> mvpa, gain maximal benefits, lifelines cohort study, 13 ), 09 ), 07 ), 004 ), cardiovascular risk factors, cardiovascular health status, 3 northern provinces, steep risk reduction, reported mvpa volumes, little health benefits Time: 0, 7, 95